ClinicalTrials.gg
CompletedNCT03256123Updated Jul 10, 2025

The Effects of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia

An interventional study of red palm shortening group and palm shortening group in Vitamin A Deficiency in Children, sponsored by Malaysia Palm Oil Board. Completed at 1 site in Malaysia. Open to participants aged 7 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Malaysia Palm Oil Board · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2017, registered Aug 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
651
Allocation
Randomized
Ages
7 Years to 11 Years
Sex
All
01

Study summary

Based on recent nutrition survey (SEANUTS Malaysia) on a total of 3542 Malaysian Children aged between 6 months to 12 years old, 4.4% of the children had vitamin A deficiency. Rural areas recorded a higher prevalence of vitamin A deficiency (6.4%) compared with urban areas (3.8%). Besides, prevalence of iron deficiency due to low ferritin concentrations is 4.4% and anaemia based on low haemoglobin concentrations is 6.6%. It is proposed that a red palm oil intervention programme to be conducted in alliance with RMT in Malaysia to enhance the Vitamin A status of school children in underprivileged community in Malaysia.

Read the detailed description

Deficiency of vitamin A or retinol is a public health problem and listed as the most widespread nutritional deficiency worldwide (Sommer, 1995). According to the World Health Organization (WHO), about 190 million preschool children in underdeveloped countries especially in the region of Africa and South-East Asia are vitamin A deficient (2011, 2011). Infants and children have higher vitamin A requirements to promote rapid growth and better immunity to combat infections. Vitamin A deficiency in children causes visual impairment and blindness, risk of infection, stunting, anemia, respiratory diseases and mortality due to common childhood infections such as diarrhea and measles. On the basis on Cochrane meta-analysis on 194,795 children, vitamin A supplementation could reduce childhood mortality by 23% and incidences of illnesses (Imdad et al., 2010).

According to WHO, an estimated 2.8 million preschool-age children are at risk of nutritional blindness or active xerophthalmia due to Vitamin A deficiency in low-income countries (Organization, 2010). Sadly, approximately 250 000 to 500 000 children suffering from vitamin A deficiency become blind yearly, and half of the number die within a year of losing their vision (Organization, 2010). The different eye signs of vitamin A deficiency (VAD) in children as graded by the WHO are night blindness, conjunctival xerosis, Bitot's spots, corneal xerosis, corneal ulcer/keratomalacia and corneal scarring (Sommer, 1995). Severe vitamin A deficiency distresses ocular tissue by reducing regeneration of visual pigment upon exposure to bright light or lasting damage on the epithelium of the cornea and conjunctiva. Classical ocular manifestation due to vitamin A deficiency may lead to less serious Bitot's spots and night blindness, or severe xerophthalmia and keratomalacia leading to blindness (Scrimshaw, 2000). Ocular manifestation of vitamin A deficiency still exists in underprivileged communities in Malaysia (Ngah et al., 2002). Vitamin A deficiency is prevalent in pre-school and primary school children of aborigines ("Orang Asli") and those from rubber estates. 82.2% of Orang Asli children had ocular manifestations of vitamin A deficiency ranging from history of night blindness to corneal scars (Ngah et al., 2002). Based on recent nutrition survey (SEANUTS Malaysia) on a total of 3542 Malaysian Children aged between 6 months to 12 years old, 4.4% of the children had vitamin A deficiency. Rural areas recorded a higher prevalence of vitamin A deficiency (6.4%) compared with urban areas (3.8%) (Poh et al., 2013).

There is significant association between iron deficiency and vitamin A deficiency represented by low serum retinol (Al-Mekhlafi et al., 2013). According to WHO, iron deficiency is the commonest and widespread nutritional deficiency in the world. Over 30% of the world's population are known to be anaemic due to iron deficiency, poor diet, or exposed to infectious diseases. Malaria, HIV/AIDS, hookworm infestation, schistosomiasis, and other infections such as tuberculosis are particularly important factors contributing to the high prevalence of anaemia in some areas. Iron deficiency may lead to impaired health, development and learning in children. Based on Malaysian SEANUTS survey, the overall prevalence of iron deficiency due to low ferritin concentrations is 4.4% and anaemia based on low haemoglobin concentrations is 6.6% (Poh et al., 2013). The occurrence of anaemia and iron deficiency among Orang Asli children is relatively high. The Orang Asli children aged 2-15 years old, living in eight villages in Selangor showed high episodes of anaemia 41.5% and 36.5% had iron deficiency anaemia. In another recent study, nearly half (48.5%) of the Orang Asli children from 18 villages in Pahang were found to be anaemic and the prevalence of iron deficiency was 34% (Al-Mekhlafi et al., 2013).

In Malaysia, the school-feeding program is called "Rancangan Makanan Tambahan (RMT)" which literally means additional food plan. The RMT program is provided only to primary school children (aged 6 - 12 years) from poor families. It is not meant to replace food served at home, but to provide extra nourishment for children from poor families. The RMT program is managed by the School Division of the Ministry of Education, Malaysia. Food is served during recess time (10.30 a.m. for morning session, and 3.30pm for afternoon session) and provides 1/4 to 1/3 of daily requirements. It is proposed that a red palm oil intervention programme to be conducted in alliance with RMT in Malaysia to enhance the Vitamin A status of school children in underprivileged community in Malaysia.

02

Conditions studied

  • Vitamin A Deficiency in Children

Keywords

  • Vitamin A Deficiency
  • Iron Deficiency
  • Parasite
  • Gut Microbiota
  • Red palm oil
03

In context

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

This study's enrollment of 651 is above the median of 200 across 49 interventional studies indexed under Vitamin A Deficiency.

Browse Vitamin A Deficiency studies →

Lead sponsor

Malaysia Palm Oil Board is the lead sponsor of 24 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 7-11 years old
  • Vitamin A deficient children defined as concentration of serum retinol \<0.70 µmol/L and suspected vitamin A deficiency defined as concentration of serum retinol 0.70 - \<1.05 µmol/L.
  • Not physically handicapped

Exclusion criteria

Exclusion Criteria:

  • Children with oedema including severe acute malnutrition or gastrointestinal disorders
  • Children allergic to wheat- and/or gluten-containing foods
  • Children who are studying Primary Six
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
651 participants (actual)

Study arms

  • Experimental
    red palm shortening group

    A group receiving the supplementation of red palm shortening biscuits. The subjects are expected to receive 326.3 µg RE of vitamin A/day by consuming the biscuits four days a week.

    Dietary Supplement: red palm shortening group

  • Placebo comparator
    palm shortening group

    A group receiving supplementation of palm shortening biscuits with corresponding fatty acids as red palm shortening group.

    Dietary Supplement: palm shortening group

Interventions

  • Dietary supplementred palm shortening group

    Biscuits made of red palm shortening will be distributed to the subjects given four days a week on schooling days for a duration of 6 months. This biscuit would be given four days a week on schooling days for a duration of 6 months. On average in a week, subject is expected to receive 326.3 µg RE of vitamin A/day. This would fulfill \~59.3% of the RNI of vitamin A for children aged 7-12 years old.

  • Dietary supplementpalm shortening group

    Biscuits made of palm shortening (control group) will be distributed to the subjects given four days a week on schooling days for a duration of 6 months. The palm shortening biscuits contain corresponding fatty acids as red palm shortening group.

06

What researchers measure

Primary outcomes

  1. Retinol level

    Vitamin A deficiency is defined as concentration of blood retinol \<0.70 µmol/L and suspected vitamin A deficiency is defined as concentration of blood retinol 0.70 - \<1.05 µmol/L.

    Time frame: During screening, after 6 months of dietary intervention period and post 200 days after the intervention.

Secondary outcomes

  1. Plasma beta carotene, alpha carotene, vitamin E levels

    Plasma beta carotene, alpha carotene, vitamin E levels are lower in Vitamin A deficiency kids

    Time frame: at the baseline, after 6 months of dietary intervention period and post 200 days after the intervention.

  2. Retinol binding protein levels

    Retinol is transported in a 1-to-1 complex with retinol-binding protein. The cutoff of equimolar RBP is able to predict vitamin A deficiency

    Time frame: at the baseline, after 6 months of dietary intervention period and post 200 days after the intervention.

  3. Haematological markers

    vitamin A is essential for normal haematopoiesis. The occurrence of anaemia is indicated by haemoglobin concentration lower than 115 g/L. The occurrence of iron deficiency is indicated by the serum ferritin concentration lower than 15 μg/L.

    Time frame: at the baseline, after 6 months of dietary intervention period and post 200 days after the intervention.

  4. Ocular signs

    Eyes examined at optimal light for conjuctival xerosis, Bitot's spots, corneal xerosis, and corneal ulceration or keratomalacia. The eye assessments include visual acuity assessment via a Snellen chart, examination with a portable slit lamp for signs of xerophthalmia, fundus photography with portable non mydriatic camera and questionnaire on night blindness symptoms.

    Time frame: at the baseline, after 6 months of dietary intervention period and post 200 days after the intervention.

  5. Inflammatory/infection status

    high sensitivity C-reactive protein (hsCRP), haematology tests

    Time frame: at the baseline, after 6 months of dietary intervention period and post 200 days after the intervention.

  6. Gut Microbiota

    As malnutrition is generally associated with the changes in gut microbiota \[14\], it is important to study the effects of red palm oil-fortified biscuit supplementation to gut microbiota of VAD children.

    Time frame: at the baseline, 3 months after intervention and after 6 months of dietary intervention period.

  7. Soil-transmitted helminth

    Malnutrition can weaken immune responses and increase the susceptibility to parasitic infections. Therefore, the supplementation of vitamin A to VAD children has the potential to boost their immunity against parasitic reinfections.

    Time frame: at the baseline, 3 months after intervention and after 6 months of dietary intervention period.

07

Study locations

1 site
  • Malaysian Palm Oil Board
    Kajang, Selangor 43000, Malaysia
08

References and documents

Publications

  • Al-Mekhlafi HM, Al-Zabedi EM, Al-Maktari MT, Atroosh WM, Al-Delaimy AK, Moktar N, Sallam AA, Abdullah WA, Jani R, Surin J. Effects of vitamin A supplementation on iron status indices and iron deficiency anaemia: a randomized controlled trial. Nutrients. 2013 Dec 31;6(1):190-206. doi: 10.3390/nu6010190. PubMed 24384995 ↗
  • van Stuijvenberg ME, Faber M, Dhansay MA, Lombard CJ, Vorster N, Benade AJ. Red palm oil as a source of beta-carotene in a school biscuit used to address vitamin A deficiency in primary school children. Int J Food Sci Nutr. 2000;51 Suppl:S43-50. doi: 10.1080/096374800750049567. PubMed 11271856 ↗
  • Zeba AN, Martin Prevel Y, Some IT, Delisle HF. The positive impact of red palm oil in school meals on vitamin A status: study in Burkina Faso. Nutr J. 2006 Jul 17;5:17. doi: 10.1186/1475-2891-5-17. PubMed 16846498 ↗
  • Tan PY, Lim CC, Seng KBH, Loganathan R, Lim YA, Teng KT, Mohd Johari SN, Selvaduray KR, Ramli N. Red palm olein supplementation as a potential preventive solution for xerophthalmia among vitamin A-deficient primary schoolchildren: a cluster randomized controlled trial. Eur J Clin Nutr. 2025 Sep;79(9):928-936. doi: 10.1038/s41430-025-01620-2. Epub 2025 Apr 17. PubMed 40247111 ↗
  • Tan PY, Loganathan R, Teng KT, Mohd Johari SN, Lee SC, Selvaduray KR, Ngui R, Lim YA. Supplementation of red palm olein-enriched biscuits improves levels of provitamin A carotenes, iron, and erythropoiesis in vitamin A-deficient primary schoolchildren: a double-blinded randomised controlled trial. Eur J Nutr. 2024 Apr;63(3):905-918. doi: 10.1007/s00394-023-03314-6. Epub 2024 Jan 19. PubMed 38240773 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2017 to primary completion in Jun 2019, 26 months.

Of 19 interventional studies with no phase under Vitamin A Deficiency, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 26 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2017
First posted
Aug 21, 2017
StartActual
Apr 1, 2017
Primary completionActual
Jun 30, 2019
CompletionActual
Jun 30, 2019
Last update
Jul 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03256123
Lead sponsor
Malaysia Palm Oil Board
Responsible party
Sponsor
First posted
Aug 21, 2017
Start date
Apr 1, 2017
Primary completion
Jun 30, 2019
Completion
Jun 30, 2019
Last update
Jul 10, 2025

Study contacts

KIM TIU TENG
principal investigator · Malaysia Palm Oil Board
RADHIKA LOGANATHAN
principal investigator · Malaysia Palm Oil Board

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion